Author | Michael W. Kattan, PhD


Combined-Modality Staging for Localized Adenocarcinoma of the Prostate

August 01, 2001

ByLouis Potters, MD, FACR, FASTRO|Michael W. Kattan, PhD|Peter T. Scardino, MD

The goal of identifying a set of pretreatment risk-stratifying factors for patients with localized prostate cancer is to be able to individualize treatment and optimize patient selection for clinical trials. Low-risk patients are most likely